JP2019537588A5 - - Google Patents

Info

Publication number
JP2019537588A5
JP2019537588A5 JP2019522962A JP2019522962A JP2019537588A5 JP 2019537588 A5 JP2019537588 A5 JP 2019537588A5 JP 2019522962 A JP2019522962 A JP 2019522962A JP 2019522962 A JP2019522962 A JP 2019522962A JP 2019537588 A5 JP2019537588 A5 JP 2019537588A5
Authority
JP
Japan
Prior art keywords
group
independently selected
phenyl
hydroxy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019522962A
Other languages
English (en)
Japanese (ja)
Other versions
JP7046940B2 (ja
JP2019537588A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/108100 external-priority patent/WO2018077246A1/zh
Publication of JP2019537588A publication Critical patent/JP2019537588A/ja
Publication of JP2019537588A5 publication Critical patent/JP2019537588A5/ja
Application granted granted Critical
Publication of JP7046940B2 publication Critical patent/JP7046940B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019522962A 2016-10-28 2017-10-27 神経栄養因子チロシンキナーゼ受容体阻害剤として用いられるアミノピラゾロピリミジン化合物 Active JP7046940B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201610970314.3 2016-10-28
CN201610970314 2016-10-28
CN201710044000 2017-01-21
CN201710044000.5 2017-01-21
PCT/CN2017/108100 WO2018077246A1 (zh) 2016-10-28 2017-10-27 用作神经营养因子酪氨酸激酶受体抑制剂的氨基吡唑并嘧啶化合物

Publications (3)

Publication Number Publication Date
JP2019537588A JP2019537588A (ja) 2019-12-26
JP2019537588A5 true JP2019537588A5 (enExample) 2022-01-21
JP7046940B2 JP7046940B2 (ja) 2022-04-04

Family

ID=62024344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019522962A Active JP7046940B2 (ja) 2016-10-28 2017-10-27 神経栄養因子チロシンキナーゼ受容体阻害剤として用いられるアミノピラゾロピリミジン化合物

Country Status (15)

Country Link
US (1) US10829492B2 (enExample)
EP (1) EP3533796B1 (enExample)
JP (1) JP7046940B2 (enExample)
KR (1) KR102616249B1 (enExample)
CN (1) CN109890820B (enExample)
AU (1) AU2017348826B2 (enExample)
CA (1) CA3041942C (enExample)
DK (1) DK3533796T3 (enExample)
ES (1) ES2896943T3 (enExample)
HU (1) HUE057733T2 (enExample)
MX (1) MX380283B (enExample)
PL (1) PL3533796T3 (enExample)
PT (1) PT3533796T (enExample)
RU (1) RU2764523C2 (enExample)
WO (1) WO2018077246A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3658148T (pt) * 2017-07-28 2024-08-26 Turning Point Therapeutics Inc Compostos macrocíclicos e utilizações dos mesmos
KR102619444B1 (ko) 2017-08-23 2023-12-29 치아타이 티안큉 파마수티컬 그룹 주식회사 아미노피라졸 및 피리미딘을 함유하는 마크로사이클 및 그의 약학적 조성물 및 용도
CN108794370A (zh) * 2018-07-31 2018-11-13 上海弈柯莱生物医药科技有限公司 一种拉罗替尼中间体的制备方法
TW202033526A (zh) * 2018-12-07 2020-09-16 大陸商貝達藥業股份有限公司 用作酪胺酸激酶抑制劑的化合物、包含其的藥物組合物及其用途
WO2020187291A1 (zh) 2019-03-19 2020-09-24 华中师范大学 吡唑并嘧啶化合物和药物组合物及其应用
CN112979654B (zh) * 2019-12-16 2024-03-19 赛诺哈勃药业(成都)有限公司 杂芳基稠环化合物、其制备方法及应用
WO2021249450A1 (zh) * 2020-06-11 2021-12-16 贝达药业股份有限公司 酪氨酸激酶抑制剂的盐型、晶型、药物组合物及其用途
CN111620881B (zh) * 2020-07-08 2023-03-31 浙江合聚生物医药有限公司 拉罗替尼衍生物及其制备方法和应用
CN113563343B (zh) * 2020-07-27 2022-05-24 杭州邦顺制药有限公司 取代的吡唑并[1,5-a]嘧啶化合物及其用途
CN112010860B (zh) * 2020-08-05 2023-03-10 南京纳丁菲医药科技有限公司 苄氧基吡唑并嘧啶化合物和药物组合物及其应用
CN114437075B (zh) * 2020-11-03 2026-01-30 上海瑶琪生物科技有限公司 用作ntrk激酶抑制剂的化合物及其应用
CN113200963A (zh) * 2021-03-31 2021-08-03 广东石油化工学院 N-(吡咯基)-3-吡唑基胺及其制备方法
EP4335441B1 (en) * 2021-05-03 2025-05-28 JBKLAB Co., Ltd. Pharmaceutical composition for preventing, alleviating, or treating cancer, containing 2,6-dichloro-4-(4-(4-hydroxycyclohexylamino)-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenol as active ingredient
CN117751121A (zh) * 2021-07-30 2024-03-22 正大天晴药业集团股份有限公司 氨基吡唑并嘧啶化合物的晶体
WO2023011616A1 (zh) * 2021-08-06 2023-02-09 正大天晴药业集团股份有限公司 氨基吡唑并嘧啶化合物在治疗trk激酶介导的肿瘤中的用途
CN117088800B (zh) * 2023-08-18 2024-05-28 龙曦宁(上海)医药科技有限公司 一种5-甲基吡咯烷-3-醇盐酸盐的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10356579A1 (de) * 2003-12-04 2005-07-07 Merck Patent Gmbh Aminderivate
CA2722418C (en) 2008-05-13 2013-09-17 Irm Llc Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
CA2727250A1 (en) 2008-07-01 2010-01-07 Genentech, Inc. Bicyclic heterocycles as mek kinase inhibitors
SI2350075T1 (sl) 2008-09-22 2014-06-30 Array Biopharma, Inc. Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
CN102264736B (zh) * 2008-10-22 2013-08-14 阵列生物制药公司 作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
WO2012034095A1 (en) * 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
BR112013021638A2 (pt) 2011-02-25 2016-08-02 Irm Llc "compostos inibidores de trk, seu uso e composições que os compreendem"
WO2013028263A1 (en) * 2011-08-24 2013-02-28 Glaxosmithkline Llc Pyrazolopyrimidine derivatives as pi3 kinase inhibitors
KR20140105508A (ko) 2011-12-12 2014-09-01 닥터 레디스 레보러터리즈 리미티드 트로포미오신 수용체 키나제(Trk) 억제제인 치환된 피라졸로[1,5-a]피리딘
MX362181B (es) 2013-02-19 2019-01-08 Ono Pharmaceutical Co Compuesto inhibidor de cinasa del receptor de tropomiosina (trk).
EP2970288A1 (en) * 2013-03-15 2016-01-20 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
CN104650092B (zh) 2013-11-16 2017-11-10 广东东阳光药业有限公司 取代的杂芳基化合物及其组合物和用途
HUE046727T2 (hu) * 2013-12-06 2020-03-30 Vertex Pharma Az ATR-kináz inhibitoraként használható vegyület, 2-amino-6-fluoro-N-[5-fluoro-piridin-3-IL]-pirazolo-[1,5-A]-pirimidin-3-karboxamid, ennek elõállítása, különbözõ szilárd formái és ezek radioaktív nyomjelzett származékai
HUE067779T2 (hu) * 2014-12-15 2024-11-28 Cmg Pharmaceutical Co Ltd Kondenzált gyûrûs heteroaril vegyületek és azok felhasználása TRK inhibitorokként

Similar Documents

Publication Publication Date Title
RU2019114600A (ru) Соединение аминопиразолопиримидина, используемое в качестве ингибитора тирозинкиназного рецептора нейротрофического фактора
JP2009542721A5 (enExample)
AR040230A1 (es) Indol, azaindol, y heterociclos relacionados de 4-alquenil piperidina
JP2013541513A5 (enExample)
CN114555588A (zh) 作为axl抑制剂的喹唑啉类化合物
HRP20201171T1 (hr) Derivati izoindolin-1-ona kao modulatori aktivnosti pozitivnog alosternog modulatora kolinergijskog muskarinskog m1 receptora za liječenje alzheimerove bolesti
JP2017525737A5 (enExample)
JP2016503009A5 (enExample)
HRP20220414T1 (hr) Inhibitori lizin specifične demetilaze-1
JP2020510670A5 (enExample)
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
JP2009542723A5 (enExample)
JP2013501720A5 (enExample)
RU2018123779A (ru) Новые соединения
JP2014516074A5 (enExample)
JP2014500296A5 (enExample)
JP2014511869A5 (enExample)
NO20063468L (no) Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister
EA201070871A1 (ru) Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии
HRP20141093T1 (hr) Triazolopirimidini
RU2013147744A (ru) Дозированная лекарственная форма для перорального применения
JP2018514544A5 (enExample)
JP2016540742A5 (enExample)
AR106735A1 (es) Composiciones y métodos insecticidas
JP2017531677A5 (enExample)